GSA Capital Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.8M Buy
382,071
+121,856
+47% +$575K 0.13% 157
2025
Q1
$1.19M Buy
260,215
+121,797
+88% +$559K 0.11% 261
2024
Q4
$663K Buy
138,418
+107,995
+355% +$517K 0.05% 698
2024
Q3
$143K Buy
+30,423
New +$143K 0.01% 1453
2024
Q2
Sell
-489,324
Closed -$2.01M 2052
2024
Q1
$2.01M Sell
489,324
-78,432
-14% -$322K 0.16% 101
2023
Q4
$2.4M Buy
567,756
+161,737
+40% +$683K 0.2% 72
2023
Q3
$1.75M Buy
406,019
+245,495
+153% +$1.06M 0.15% 148
2023
Q2
$1.06M Buy
160,524
+73,187
+84% +$482K 0.11% 273
2023
Q1
$593K Sell
87,337
-38,029
-30% -$258K 0.06% 605
2022
Q4
$926K Buy
125,366
+73,500
+142% +$543K 0.11% 249
2022
Q3
$512K Buy
+51,866
New +$512K 0.07% 554
2022
Q2
Sell
-28,482
Closed -$322K 1829
2022
Q1
$322K Buy
28,482
+10,390
+57% +$117K 0.04% 844
2021
Q4
$284K Buy
+18,092
New +$284K 0.04% 973
2020
Q1
Sell
-22,135
Closed -$363K 1587
2019
Q4
$363K Sell
22,135
-30,459
-58% -$500K 0.04% 878
2019
Q3
$698K Buy
+52,594
New +$698K 0.09% 337
2019
Q1
Sell
-11,945
Closed -$312K 1706
2018
Q4
$312K Sell
11,945
-4,253
-26% -$111K 0.04% 816
2018
Q3
$372K Buy
+16,198
New +$372K 0.02% 1221
2017
Q1
Sell
-14,535
Closed -$232K 2011
2016
Q4
$232K Sell
14,535
-3,269
-18% -$52.2K 0.01% 1502
2016
Q3
$296K Buy
+17,804
New +$296K 0.02% 1382
2016
Q2
Sell
-31,180
Closed -$261K 1934
2016
Q1
$261K Buy
31,180
+7,341
+31% +$61.5K 0.02% 1372
2015
Q4
$222K Sell
23,839
-28,831
-55% -$268K 0.01% 1606
2015
Q3
$594K Buy
+52,670
New +$594K 0.03% 1030
2014
Q3
Sell
-14,828
Closed -$240K 1946
2014
Q2
$240K Sell
14,828
-12,710
-46% -$206K 0.01% 1526
2014
Q1
$447K Buy
+27,538
New +$447K 0.03% 862
2013
Q4
Sell
-10,212
Closed -$112K 1777
2013
Q3
$112K Buy
+10,212
New +$112K 0.01% 1486